Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway

References

• Aceto A, DiIlio C, Angelucci S, et al. (1989). Glutathione transferases in human nasal mucosa. Arch Toxicol 63:427–31
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. (2004). Recent advances on chitosan based micro-and nanoparticles in drug delivery. J Control Rel 100:5–28
   PubMed Web of Science ®Google Scholar
• Balin BJ, Broadwell RD, Salcman M, El-Kalliny M. (1986). Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J Comp Neurol 251:260–80
   Google Scholar
• Brittebo EB, Eriksson C. (1995). Taurine in the olfactory system: effects of the olfactory toxicant dichlobenil. Neurotoxicology 16:271–80
   PubMed Web of Science ®Google Scholar
• Brunton LL, Lazo JS, Parker EL. (2008). Local anaesthetic. Goodman & Gilman’s the pharmacological basis of therapeutics. 11th ed. OH, USA: The MacGraW-Hill Companies
   Google Scholar
• Calvo P, Remunan C, VilaJato JL, Alonso MJ. (1997). Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsule and submicron emulsions. Colloid Polym Sci 275:46–53
   Web of Science ®Google Scholar
• Chou KJ, Donovan MD. (1998). The distribution of local anaesthetics into the CSF following intranasal administration. Int J Pharm 168:137–45
   Web of Science ®Google Scholar
• Eriksson C, Bergman U, Franzen A, et al. (1999). Transfer of some carboxylic acids in the olfactory system following intranasal administration. J Drug Target 7:131–42
   PubMed Web of Science ®Google Scholar
• Felt O, Buri P, Gurny R. (1998). Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 24:979–93
   PubMed Web of Science ®Google Scholar
• Frey WH, Liu J, Chen X, et al. (1997). Delivery of 125I-NGF to the brain via the olfactory route. Drug Deliv 4:87–2
   Web of Science ®Google Scholar
• Henriksson J, Tjalve H. (1998). Uptake of inorganic mercury in the olfactory bulbs via olfactory pathways in rats. Environ Res 77:130–40
   PubMed Web of Science ®Google Scholar
• Illum L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326–31
   PubMed Web of Science ®Google Scholar
• Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1–18
   PubMed Web of Science ®Google Scholar
• Kumar TCA, David GF, Sankaranarayanan A, et al. (1982). Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying. Proc Natl Acad Sci USA 79:4185–9
   PubMed Web of Science ®Google Scholar
• Levin VA. (1980). Relationship of octanol/water partition coefficients and molecular weight to rat brain capillary permeability. J Med Chem 23:682–4
   PubMed Web of Science ®Google Scholar
• Lewis JL, Nikula KJ, Novak R, Dahl AR. (1994). Comparative localization of carboxyl esterase in F344 rat, beagle dog and human nasal tissue. Anat Rec 239:55–64
   PubMedGoogle Scholar
• Mathison S, Nagilla R, Kompella UB. (1998). Nasal route for direct delivery of solutes to the central nervous system: fact or fiction. J Drug Target 5:415–41
   PubMed Web of Science ®Google Scholar
• Merkus FW, van den Berg MP. (2007). Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory. Drugs R D 8:133–44
   PubMedGoogle Scholar
• Mustafa G, Ahmad N, Baboota S, et al. (2012b). Stressed kinetics of nanoemulsion formulation encapsulated ropinirole with a validated ultra high performance liquid chromatography–synapt mass spectrometry (UPLC-MS/MS ESI-Q-TOF). J Chin Chem Soc 59:1021–30
   Google Scholar
• Mustafa G, Baboota S, Ahuja A, Ali J. (2012c). formulation development of chitosan coated intra nasal ropinirole nanoemulsion for better management option of parkinson: an in vitro ex vivo evaluation. Current Nanoscience 8:348–60
   Google Scholar
• Mustafa G, Baboota S, Ali J, et al. (2013) Nose to Brain targeting potential of a chitosan coated nanoformulation: Pharmacodynamic and Pharmacoscintigraphic evaluation. Sci Adv Mat 5:1236–49
   Google Scholar
• Mustafa G, Khan ZI, Bansal T, Talegaonkar S. (2009). Preparation and characterization of oil in water nano-reservoir systems for improved oral delivery of atorvastatin. Curr Nano Sci 5:428–40
   Web of Science ®Google Scholar
• Mustafa G, Kumar N, Singh T, Baboota et al. (2012a) Effect of homogenization on the fate of true nanoemulsion in brain translocation: a gamma scintigraphic evaluation. Sci Ad Material 4:739–48
   Google Scholar
• Nattel S, Gagne G, Pineau M. (1987). The pharmacokinetics of lignocaine and -adrenoceptor antagonists in patients with acute myocardial infarction. Clin Pharmacokinet 13:293–316
   PubMed Web of Science ®Google Scholar
• Sakane T, Akizuki M, Yamashita S, et al. (1991). The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. Chem Pharm Bull 39:2456–8
   PubMed Web of Science ®Google Scholar
• Shipley MT. (1985). Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull 15:129–42
   PubMed Web of Science ®Google Scholar
• Singla AK, Chawla M. (2001). Chitosan: some pharmaceutical and biological aspects-an update. J Pharm Pharmacol 53:1047–67
   PubMed Web of Science ®Google Scholar
• Stakic J, Suchanek JM, Ziegler GP, Griff ER. (2011). The source of spontaneous activity in the main olfactory bulb of the rat. PLoS ONE 6:e23990
   PubMed Web of Science ®Google Scholar
• Stevens J, Ploeger BA, van der Graaf PH, et al. (2011). Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administration. Drug Metab Dispos 39:2275–82
   PubMed Web of Science ®Google Scholar
• Talegaonkar S, Mustafa G, Akhter S, Iqbal ZI. (2009). Design and development of oral oil-in-water nanoemulsion formulation bearing atorvastatin: in vitro assessment. J Disp Sci Tech 30:1–12
   Web of Science ®Google Scholar
• Thorne RG, Frey WH. (2001). Delivery of neurotrophic factors to the central nervous system. Clin Pharma 40:907–46
   Google Scholar
• Turker S, Onur E, Ozer Y. (2004). Nasal route and drug delivery systems. Pharm World Sci 26:137–42
   PubMed Web of Science ®Google Scholar
• Wang Y, Aun R, Tse FLS. (1998). Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat. Biopharm Drug Dispos 19:571–5
   PubMed Web of Science ®Google Scholar
• Wen MM. (2011). Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development. Discov Med 11:497–503
   PubMed Web of Science ®Google Scholar
• Wils P, Warnery A, Phung-Ba V, et al. (1994). High lipophilicity decreases drug transport across intestinal epithelial cells. J Pharmacol Exp Ther 269:654–8
   PubMed Web of Science ®Google Scholar
• Yajima T, Juni K, Saneyoshi M, et al. (1998). Direct transport of 2′,3′-didehydro-3′-deoxythymidine (D4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in rats. Biol Pharm Bull 21:272–7
   PubMed Web of Science ®Google Scholar
• Yao J, Zhou JP, Ping QN, et al. (2008). Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice. Int J Pharm 352:256–62
   PubMed Web of Science ®Google Scholar
• Yu CR, Power J, Barnea G, et al. (2004). Spontaneous neural activity is required for the establishment and maintenance of the olfactory sensory map. Neuron 42:553–66
   PubMed Web of Science ®Google Scholar